Safety study of JANX011 in healthy adults
Part of Immune system & allergy clinical trials.
This trial tests a new drug called JANX011 in healthy adults to see if it is safe and well tolerated. It is a first step before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh between 110 and 265 pounds (50–120 kg) and your BMI is between 18 and 32.
- You are generally healthy, as determined by a doctor and lab tests.
- You have not had major surgery with general anesthesia in the last 12 weeks.
- You are not positive for hepatitis B, C, HIV, or tuberculosis.
- You have not taken any other experimental drug or device in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This is a first-in-human safety study testing a new experimental immune therapy called JST-018. Researchers want to see how safe it is, how well your body tolerates it, and how your body processes it when given as an injection.
This trial is testing a new study drug called XKH001 in healthy volunteers to see how it affects the body. It is the first time this drug is being studied in people of European descent.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
This study tests a new investigational drug called BLX-0871 in healthy adults to see how safe it is and how the body processes it. Participation may help determine the right dose for future studies, but it will not treat any existing condition.
Hear when a new Autoimmune trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.